Smith & Nephew plc has agreed to pay $240m in cash to acquire Integra Lifesciences’ extremity orthopedics business, the companies announced on 29 September.
Smith & Nephew Pays $240M For Integra’s Extremities Business
Integra is divesting its underperforming extremity orthopedics product portfolio to focus on its neurosurgery, surgical instrument and regenerative medicine businesses.
